EMS Chemie rises after H1 sales beat expectations
BUZZ-EMS Chemie rises after H1 sales beat expectations ** Shares in EMS Chemie EMSN.S rise around 3% after the Swiss chemicals company reported H1 sales above expectations and slightly lifted its FY sales guidance
** EMS Chemie posts H1 sales of 1.01 billion Swiss francs ($1.25 billion), down 0.8% y/y
** Vontobel says the company delivered a good set of results and its H1 revenue was clearly better than consensus and the broker's estimates
** Vontobel says the beat is driven by new business and applications, while profitability is in line
** EMS now expects FY net sales to come in "slightly below" previous year due to currency effects, having previously forecast sales to be "below 2025"
** The stock, which has gained 27.5% YTD including Friday's session, is among the best performers of Switzerland's mid-cap index .SMIM
($1 = 0.8054 Swiss francs)
(Reporting by Ozan Ergenay)
Recent news on Ems Chemie Holding AG
See all newsEMS Chemie falls, analyst points to profit taking
EMS-Chemie raises full-year sales guidance on strong new business
Swiss stocks - Factors to watch on October 22
Brief: EMS Chemie Holding AG - 9M 2026 Net Sales 1.509 Billion CHF Versus 1.491 Billion Year Before
Swiss stocks - Factors to watch on August 11